New drugstore cialis australia online with a lot of generic and brand drugs with mean price and fast delivery.

Wissenschaftliche publikationen augen

Wissenschaftl. Publikationen der Augenabteilung am Akh Linz
1. An in-vivo Evaluation of Brilliant Blue G in Macular Surgery. Höing A, Remy M,
Dirisamer M, Priglinger S, Schönfeld CL, Kampik A, Haritoglou C. Klin Monbl Augenheilkd. 2011 Apr 8. [Epub ahead of print] IF: 0,470 2. Quantification of Contrast Recognizability During Brilliant Blue G (BBG) and Indocy-
anine Green (ICG) Assisted Chromovitrectomy. Henrich PB, Priglinger SG, Haritoglou
C, Josifova T, Ferreira PR, Strauss RW, Flammer J, Cattin PC. Invest Ophthalmol Vis Sci. 2011 Mar 2. [Epub ahead of print] IF: 3,58 3. Endothelial cell density after Descemetmembrane endothelial keratoplasty:1-4 year
follow-up. Parker J, Dirisamer M, Naveiras M, Ham L, van der Wees J, Melles G. AJO
2011, accepted for publication IF: 3,10 4. Descemet membrane endothelial transfer (DMET): Free floating donor Descemet im-
plantation as a potential alternative to ‘keratoplasty’. Dirisamer M, Ham L, Dapena I,
Naveiras M, van Dijk K, van der Wees J, Melles G. CORNEA 2011 accepted for publication 5. Patterns of corneal endothelialization and corneal clearance after Descemet memb-
rane endothelial keratoplasty for Fuchs endothelial dystrophy Dirisamer M, Dapena I,
Ham L, Naveiras M, van Dijk K, Oganes O, Frank L, van der Wees J, Melles G. AJO 2011 6. Secondary ‘Thin DSEK’ after longterm graft failure in DLEK: A double transplant-
ed.Dirisamer M, Acis G, Dapena I, Ham L, Versteeg F, Melles G. Cornea 2011, accepted
7. Efficacy of Descemet membrane endothelial keratoplasty (DMEK): Clinical outcome
of 200 consecutive cases after a ‘learning curve’ of 25 cases. Dirisamer M, Ham L,
Dapena I, Moutsouris K, Droutsas K, van Dijk K, Frank L, van der Wees J, Oellerich S, Melles G. Arch of Ophthalm. 2011, accepted for publication IF: 3,2 8. Static Retinal Vessel Analysis in Acute Blood Pressure Increase. Strauss RW, Lüdtke
U, Kampik A, Neubauer AS. Klin Monbl Augenheilkd. 2011 Mar 25. [Epub ahead of print] 9. Anatomic Success of Scleral Buckling for Rhegmatogenous Retinal Detachment - A
Retrospective Study of 524 Cases. Haritoglou C, Brandlhuber U, Kampik A, Priglinger SG
Ophthalmologica. 2010 Mar 23;224(5):312-318 IF: 1.093 10. ARMS2 is a constituent of the extracellular matrix providing a link between familial
and sporadic age-related macular degenerations. Kortvely E, Hauck SM, Duetsch G,
Gloeckner CJ, Kremmer E, Alge-Priglinger CS, Deeg CA, Ueffing M. Invest Ophthalmol Vis Sci. 2010 Jan;51(1):79-88. Epub 2009 Aug IF: 3,6 11. Negative regulation of RPE cell attachment by carbohydrate-dependent cell surface
binding of galectin-3 and inhibition of the ERK-MAPK pathway. Alge-Priglinger CS,
André S, Schoeffl H, Kampik A, Strauss RW, Kernt M, Gabius HJ, Priglinger SG. Biochimie. 12. Ultrastructure and retinal imaging of internal limiting membrane: a clinicopathologic
correlation of trypan blue stain in macular hole surgery. Mackenzie SE, Gandorfer A,
Rohleder M, Schumann R, Schlottmann PG, Bunce C, Xing W, Gregor Z, Charteris DG. Retina. 2010 Apr;30(4):655-61. IF: 3,5 13. Amadeus II microkeratome: optimizing microkeratome settings for high flap accura-
cy using optical low coherence reflectometry.Lackerbauer CA, Kollias A, Kreutzer TC,
Ulbig M, Kampik A, Grueterich M. Eur J Ophthalmol. 2010 Jan-Feb;20(1):41-7. IF. 1,0 14. Sorafenib prevents human retinal pigment epithelium cells from light-induced over-
expression of VEGF, PDGF and PlGF. Kernt M, Neubauer AS, Liegl RG, Hirneiss C, Alge
CS, Wolf A, Ulbig MW, Kampik A. Br J Ophthalmol. 2010 Nov;94(11):1533-9. IF: 2,9 15. Indocyanine green increases light-induced oxidative stress, senescence, and matrix
metalloproteinases 1 and 3 in human RPE cells. Kernt M, Hirneiss C, Wolf A, Liegl R,
Rueping J, Neubauer A, Alge C, Ulbig M, Gandorfer A, Kampik A, Haritoglou C Acta Oph- 16. Vital dyes for macular surgery: a comparative electron microscopy study of the in-
ternal limiting membrane. Schumann RG, Gandorfer A, Priglinger SG, Kampik A, Harito-
glou C. Retina. 2009; 29:669-76. IF: 3,478 17. Macula-off retinal detachment--a matter of time? Henrich PB, Priglinger S, Klaessen D,
Kono-Kono JO, Maier M, Schötzau A, Meyer P, Josifova T, Schneider U, Flammer J, Hari- toglou C. Klin Monatsbl Augenheilkd. 2009; 226:289-93. IF: 0,470 18. Alkylphosphocholines as a potential pharmacologic prophylaxis for posterior cap-
sule opacification.Eibl KH, Liegl R, Kernt M, Priglinger S, Kampik A. J Cataract Refract
19. Optimizing the deswelling process of organ-cultured corneas.Wolf AH, Welge-Lüssen
UC, Priglinger S, Kook D, Grueterich M, Hartmann K, Kampik A, Neubauer AS. Cornea. 20. Anatomical and functional outcome in brilliant blue G assisted chromovitrectomy.
Henrich PB, Haritoglou C, Meyer P, Ferreira PR, Schötzau A, Katamay R, Josifova T, Schneider U, Flammer J, Priglinger S. Acta Ophthalmol. 2009 Apr 23. IF: 2.138 21. Oxidative Stress-mediated Induction of MMP-1 and MMP-3 in human RPE cells. Alge-
Priglinger CS, Kreutzer T, Obholzer Katja, Wolf A, Mempel M, Kernt M, Kampik A, Priglin- ger SG. Invest Ophthalmol Vis Sci. 2009 Jun 10 . IF: 3,582 22. Two-step LASIK after penetrating keratoplasty. Kollias AN, Schaumberger MM, Kreut-
zer TC, Ulbig MW, Lackerbauer CA. Clin Ophthalmol. 2009;3:581-6. Epub 2009 Nov 2. 23. Intracameral moxifloxacin: in vitro safety on human ocular cells. Kernt M, Neubauer
AS, Liegl RG, Lackerbauer CA, Eibl KH, Alge CS, Ulbig MW, A AK. Cornea. 2009 24. Cytoprotective effects of a blue light-filtering intraocular lens on human retinal pig-
ment epithelium by reducing phototoxic effects on vascular endothelial growth fac-
tor-alpha, Bax, and Bcl-2 expression. Kernt M, Neubauer AS, Liegl R, Eibl KH, Alge CS,
Lackerbauer CA, Ulbig MW, Kampik A. J Cataract Refract Surg. 2009 Feb;35(2):354-62. IF: 25. A prospective study determining the efficacy of topical 0.5% levofloxacin on bacteri-
al flora of patients with chronic blepharoconjunctivitis. Yactayo-Miranda Y, Ta CN, He
L, Kreutzer TC, Nentwich MM, Kampik A, Mino de Kaspar H. Graefes Arch Clin Exp Oph- thalmol. 2009 Jul;247(7):993-8. Epub 2009 Feb 11. IF: 1,8 26. Experimental evaluation of aniline and methyl blue for intraocular surgery. Haritoglou
C, Priglinger S, Liegl R, May CA, Eibl K, Thaler S, Kampik A, Schuettauf F. Retina. 2009 Oct;29(9):1266-73. IF: 3,478 27. Inhibition of human retinal pigment epithelial cell attachment, spreading, and migra-
tion by the human lectin galectin-1. Alge-Priglinger CS, André S, Kreutzer TC, Deeg CA,
Kampik A, Kernt M, Schöffl H, Priglinger SG, Gabius HJ. Mol Vis. 2009 Oct 23;15:2162-73. 28. Intravitreal bevacizumab for choroidal neovascularization secondary to inflamma-
tion. Wolf A, Thurau S, Kook D, Hoeing A, Priglinger S, Kampik A, Haritoglou C. Acta Oph-
29. Intravitreal bevacizumab for the treatment of macular oedema secondary to branch
retinal vein occlusion. Kreutzer TC, Alge CS, Wolf AH, Kook D, Burger J, Strauss R,
Kunze C, Haritoglou C, Kampik A, Priglinger SG. Br J Ophthalmol. 2008; 92:351-5. IF: 30. Delineation of the vitreous and posterior hyaloid using bromophenol blue. Haritoglou
C, Strauss R, Priglinger SG, Kreutzer T, Kampik A. Retina. 2008; 28:333-9. IF: 3,5 31. Intrakamerale Lidocainanästhesie bei Kataraktoperationen: Effektivität und Sicher-
heit der Applikation während der Hydrodissektion; E. Schmid, T. Neumayer, G. Rainer,
M. Georgopoulos, B. Kremser, M. Luger, O. Findl; Spektrum der Augenheilkunde (2008) 32. Calcium-phosphate deposits on a hydrophilic acrylic intraocular lens after silicon oil
tamponade. Alsaeidi R, Priglinger SG, Nachbauer J, Lackerbauer C, Kampik A, Haritoglou
C. Oman Journal of Ophthalmology, 2008; 1: 25-27.IF: 3,478 33. Retinal vessel analysis reproducibility in assessing cardiovascular disease. Neu-
bauer AS, Lüdtke M, Haritoglou C, Priglinger S, Kampik A. Optom Vis Sci. 2008; 85:247- 34. The protective effect of quercetin against oxidative stress in the human RPE in vitro.
Kook D, Wolf AH, Yu AL, Neubauer AS, Priglinger SG, Kampik A, Welge-Lüssen UC. In- vest Ophthalmol Vis Sci. 2008; 49:1712-20. IF: 3,582 35. Capsular tension ring-based in vitro capsule opacification model. Burger J, Kreutzer
T, Alge CS, Strauss RW, Eibl K, Haritoglou C, Neubauer AS, Kampik A, Priglinger SG. J Cataract Refract Surg. 2008; 34:1167-72. IF: 2,508 36. An in vivo evaluation of Brilliant Blue G in animals and humans. Remy M, Thaler S,
Schumann RG, May CA, Fiedorowicz M, Schuettauf F, Grüterich M, Priglinger SG, Nentwich MM, Kampik A, Haritoglou C. Br J Ophthalmol. 2008; 92:1142-7. IF: 2.859 37. Nonmydriatic screening for diabetic retinopathy by ultra-widefield scanning laser
ophthalmoscopy (Optomap). Neubauer AS, Kernt M, Haritoglou C, Priglinger SG, Kampik
A, Ulbig MW. Graefes Arch Clin Exp Ophthalmol. 2008; 246:229-35.IF: 1,498 38. Idiopathic macular holes: ultrastructural aspects of surgical failure.Schumann RG,
Rohleder M, Schaumberger MM, Haritoglou C, Kampik A, Gandorfer A. Retina. 2008 39. Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic dif-
fuse diabetic macular edema. Kook D, Wolf A, Kreutzer T, Neubauer A, Strauss R, Ulbig
M, Kampik A, Haritoglou C. Retina. 2008 Oct;28(8):1053-60. 40. A prospective randomized study to determine the efficacy of preoperative topical
levofloxacin in reducing conjunctival bacterial flora. Miño de Kaspar H, Kreutzer TC,
Aguirre-Romo I, Ta CN, Dudichum J, Bayrhof M, Klauss V, Kampik A. Am J Ophthalmol. 2008 Jan;145(1):136-142. Epub 2007 Nov 8. 41. Staining and peeling of the internal limiting membrane using a fluorescent dye (Rho-
damine 6 G). Haritoglou C, Kreutzer T, Tadayoni R, Langhals H, May CA, Thaler S,
Kampik A. Br J Ophthalmol. 2008 Sep;92(9):1265-8. Epub 2008 Jun 27. 42. Anti-VEGF treatment for retinal angiomatous proliferation.Wolf A, Kook D, Kreutzer T,
Gandorfer A, Haritoglou C, Kampik A, Ulbig M. Ophthalmologe. 2008 Sep;105(9):845-51. 43. Retinal pigment epithelial tears after intravitreal injection of bevacizumab for AMD:
Frequency and progress. Kook D, Wolf A, Neubauer AS, Haritoglou C, Priglinger SG,
Kampik A, Ulbig MW. Ophthalmologe. 2008;105:158-64. 44. Visual quality of life after Macular Hole Surgery: Outcome and predictive factors. Hir-
neiss C, Neubauer AS, Gass CA, Reiniger IW, Priglinger SG, Kampik A, Haritoglou C. Br J 45. Topography of Diabetic Macular Edema compared to Fluorescein Angiography.
Neubauer AS, Chryssafis C, Priglinger SG, Haritoglou C, Thiel M, Welge-Lüßen U, Kampik A, Ulbig M. Acta Ophthalmol Scand. 2007;85:32-9.IF: 2,138. IF: 2,859 46. Hypoxia/Reoxygenation and TGF-beta Increase alphaB-Crystallin Expression in Hu-
man Optic Nerve Head Astrocytes. Yu AL, Fuchshofer R, Birke M, Priglinger SG, Eibl
KH, Kampik A, Bloemendal H, Welge-Lussen U. Exp Eye Res. 2007;84:694-706. IF: 2,579 47. Long-term functional outcome of macular hole surgery correlated to Optical Coher-
ence Tomography (OCT) measurements. Haritoglou C, Neubauer A, Reiniger IW,
Priglinger SG, Gass CA, Kampik A. Clin Experiment Ophthalmol. 2007;35:208-13. IF: 1,347 48. Pulsed Electron Avalanche Knife (PEAK-fc): New Technology for Cataract Surgery.
Priglinger SG, Palanker D, Alge CS, Haritoglou H, Grueterich M, Kampik A. Br J Ophthal- mol. Br J Ophthalmol. 2007; 91:949-54.IF: 2,859 49. Vitreoretinal surgery using Bromphenol blue as a vital stain: Evaluation of staining
characteristics in humans. Haritoglou C, Schumann R, Strauss R, Priglinger S, Neubauer
AS, Kampik A. Br J Ophthalmol. 2007; 91:1125-8.IF: 2,859 50. Eccentric lamellar keratolimbal grafts harvested with a manually guided microker-
atome. Technical report. Grueterich M, Kenyon KR, Priglinger S, Welge-Luessen U, La-
ckerbauer C, Kampik A. Ophthalmic Res. 2007; 39:179-83.IF: 1,317 51. Intravitreal Bevacizumab for Central Retinal Vein Occlusion - Six Month Results of a
Prospective Trial. Priglinger SG, Wolf AH, Kreutzer TC, Kook D, Hofer A, Strauss RW, Al-
ge CS, Kunze C, Haritoglou C, Kampik A. Retina. 2007; 27:1004-12.IF: 3,478 52. Indications and Clinical Outcome of Capsular Tension Ring (CTR) Implantation: A
Review of 9528 Cataract Surgeries.Tribus C, Alge CS, Haritoglou C, Kampik A, Mueller
A. Priglinger SG. Clinical Ophthalmology. 2007;1(1) 65-69. IF: 1,347 53. Image quality characteristics of a novel colour scanning digital ophthalmoscope
(SDO) compared with fundus photography. Strauss RW, Krieglstein TR, Priglinger SG,
Reis W, Ulbig MW, Kampik A, Neubauer AS. Ophthalmic Physiol Opt. 2007; 27:611-8. IF: 54. Bevacizumab and retinal ischemia. Neubauer AS, Kook D, Haritoglou C, Priglinger SG,
Kampik A, Ulbig MW, Ceklic L. Ophthalmology. 2007; 114:2096. IF: 5,296 55. Bromphenol blue staining in eyes with mature cataract. Haritoglou C, Priglinger SG,
Strauss R, Gandorfer A, Kampik A. J Cataract Refract Surg. 2007; 33:2155-7. IF: 2,508 56. Light absorbing properties of indocyanine green (ICG) in solution and on the retinal
surface – an ex vivo approach. Haritoglou C, Freyer W, Priglinger SG, Kampik A. Graefes
Arch Clin Exp Ophthalmol. 2006; 244:1196-202. 57. Galectin-1 influences migration of retinal pigment epithelial cells. *Alge CS, *Priglinger
SG, Kook D, Haritoglou C, Welge-Luessen U, Kampik A. Invest Ophthalmol Vis Sci. 2006; 47:415-426. (*contributed equally). IF: 3,582 58. Inhibition of Human Retinal Pigment Epithelial Cell Attachment, Spreading and Mi-
gration by Alkylphosphocholines through Microfilament Modification. Eibl KH, Kook
D, Priglinger S, Haritoglou C, Kampik A, Welge-Luessen U. Invest Ophthalmol Vis Sci. 59. Ultrastructure of the vitreomacular interface in full-thickness idiopathic macular ho-
les: a consecutive analysis of 100 cases. Schumann RG, Schaumberger MM, Rohleder
M, Haritoglou C, Kampik A, Gandorfer A. Am J Ophthalmol. 2006 Jun;141(6):1112-1119. 60. Evaluation of the internal limiting membrane after conventional peeling during macu-
lar hole surgery. Haritoglou C, Schumann R, Reiniger I, Rohleder M, Priglinger SG, Kam-
pik A, Gandorfer A. Retina 2006; 26:21-24. IF: 3,478 61. Immunohistochemical findings after LASIK confirm in vitro LASIK model. Priglinger
SG, May CA, Alge CS, Wolf A, Neubauer AS, Haritoglou C, Kampik A, Welge-Lüßen U. Cornea. 2006; 25:331-335. IF: 1,853 62. Differential protein profiling of primary versus immortalized human RPE cells identi-
fies expression patterns associated with cell-matrix interactions and cell survival.
Alge CS, Hauck SM, Priglinger SG, Kampik A, Ueffing M. J Proteome Res. 2006; 5:862- 63. Klinische Aspekte bei Frühgeborenen-Retinopathie (ROP). Ergebnisse nach Dioden-
Laserkoagulation. Rudolph G, Buhl M, Pietschmann M, Priglinger S, Boergen K-P, Kam-
pik A. Klin Monatsbl Augenheilkd. 2006; 223:528-533. IF: 0,470 64. Five year follow-up of macular hole surgery with peeling of the internal limiting
membrane (ILM): Update of a prospective study. Haritoglou C, Reiniger I, Schaumberg-
er M, Gass C, Priglinger SG, Kampik A. Retina 2006; 26:618-622. IF: 3,478 65. Tissue Transglutaminase modifies Extracellular Matrix after Glaucoma Filtrating
Surgery Priglinger SG, Alge CS, Kook D, Thiel M, Schumann R, Kampik A, Welge-
Luessen U. Invest Ophthalmol Vis Sci. 2006;47:3835-45. IF: 3,58 66. Pulsed Electron Avalanche Knife (PEAK-fc): New Technology for capsulotomy in
congenital and mature cataract. Priglinger SG, Haritoglou C, Palanker D, Kook D, Grue-
terich M, Mueller A, Alge CS, Kampik A. J Cataract Refract Surg. 2006;32:1085-1088. IF: 67. Short time in vivo evaluation of novel vital dyes for intraocular surgery. Haritoglou C,
Tadayoni R, May CA, Gass C, Freyer W, Priglinger SG, Kampik A. Retina 2006; 26:673- 68. Keratinocyte transglutaminase in proliferative vitreoretinopathy. Priglinger SG, Alge
CS, Kreutzer TC, Neubauer AS, Haritoglou C, Kampik A, Welge-Luessen U. Invest Oph- thalmol Vis Sci. 2006; 47:4990-4997. IF: 3,582 69. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular
edema. Haritoglou C, Kook D, Neubauer AS, Wolf A, Priglinger S, Strauss R, Gandorfer A,
Ulbig M, Kampik A. Retina. 2006; 26:999-1005. IF: 3,478 70. Histology of the vitreoretinal interface after indocyanine green staining of the ILM
with illumination using a halogen and xenon light source. Haritoglou C, Priglinger SG,
Gandorfer A, Welge-Luessen U, Kampik A. Invest Ophthalmol Vis Sci 2005; 46: 1468-72. 71. Staining and peeling of the internal limiting membrane in the cat eye. Gandorfer A,
Rohleder M, Charteris DG, Sethi C, Kampik A, Luthert P. Curr Eye Res. 2005 72. Use of rapid antibiotic susceptibility testing in bacterial endophthalmitis. de Kaspar
HM, Kreutzer TC, Ta CN, Kampik A. Retina. 2005 Apr-May;25(3):386-7; author reply 387-8. 73. Epiretinal pathology of diffuse diabetic macular edema associated with vitreomacu-
lar traction. Gandorfer A, Rohleder M, Grosselfinger S, Haritoglou C, Ulbig M, Kampik A.
Am J Ophthalmol. 2005 Apr;139(4):638-52. 74. Ultrastructure of vitreomacular traction syndrome associated with persistent hyaloid
artery. Gandorfer A, Rohleder M, Charteris D, Kampik A, Luthert P. Eye (Lond). 2005
75. Pulsed Electron Avalanche Knife (PEAK-fc) in vitreoretinal surgery: Priglinger SG, Ha-
ritoglou C, Mueller A, Grueterich M, Strauss RW, Alge CS, Gandorfer A, Palanker D, Kam- pik A. Retina. 2005;25:889-896IF: 3,478 76. Pulsed Electron Avalanche Knife (PEAK-fc®) for Dissection of Retinal Tissue. Pri-
glinger SG, Haritoglou C, Palanker DV, Alge CS, Gandorfer A, Kampik A. Arch Ophthalmol. 2005 Oct;123(10):1412-8.IF: 3,242 77. An evaluation of novel dyes for intraocular surgery. Haritoglou C, Yu A, Freyer W, Pri-
glinger SG, May CA, Alge C, Eibl K, Welge-Luessen U, Kampik A. Invest Ophthalmol Vis 78. Absence of scar formation in a human donor cornea with prior laser in situ kera-
tomileusis (LASIK). Priglinger SG, May CA, Alge CS, Wolf A, Neubauer AS, Kampik A,
Welge-Lüßen U J Cataract Refract Surg. 2005;31:1403-1408.IF: 2,508 79. Mapping of retinal pigment epithelium in exudative age related macular degenera-
tion. Neubauer AS, Thiel M, Priglinger S, Chryssafis C, Alge C, Welge-Lüßemn U, Kampik
A. Graefes Arch Clin Exp Ophthalmol. 2005;18:1-10; IF: 1,77 80. Screening der diabetischen Retinopathie und Papillentopographie mit dem “Retinal
Thickness Analyzer” (RTA) Neubauer AS, Chryssafis C, Thiel M, Priglinger S, Welge-
Lussen U, Kampik A. Ophthalmologe. 2005;102:251-8. IF: 1,133 81. Laser in situ keratomileusis in human corneas; New organ culture model. May* CA,
Priglinger* SG, Neubauer AS, Alge CS, Ludwig K, Kampik A, Welge-Lüßen U. J Cataract Refract Surg. 2004 Jan;30(1):186-93. (* contributed equally). IF: 2,508 82. Posterior vitreous detachment induced by microplasmin. Gandorfer A, Rohleder M,
Sethi C, Eckle D, Welge-Lüssen U, Kampik A, Luthert P, Charteris D. Invest Ophthalmol 83. TGF-beta2-Induced Cell Surface Tissue Transglutaminase Increases Adhesion and
Migration of RPE Cells on Fibronectin through the Gelatin-Binding Domain. Priglinger
SG, Alge CS, Neubauer AS, Kristin N, Hirneiss C, Eibl K, Kampik A, Welge-Lussen U. In- vest Ophthalmol Vis Sci. 2004 Mar;45(3):955-63. IF: 3,582 84. Alkylphosphocholines: A New Therapeutic Option in Glaucoma Filtration Surgery.
Eibl KH, Banas B, Kook D, Ohlmann A, Priglinger S, Kampik A, Welge-Luessen U. Invest Ophthalmol Vis Sci. 2004; 45:2619-24. IF: 3,582 85. Functional outcome after trypan-blue-assisted vitrectomy for macular pucker: a pro-
spective, randomized, comparative trial. Haritoglou C, Eibl K, Schaumberger M, Müller
AJ, Priglinger S, Alge C, Kampik A. Am J Ophthalmol 2004; 138: 1-5. IF: 3,102 86. Trypan blue in macular pucker surgery: an evaluation of histology and functional
outcome. Haritoglou C, Gandorfer A, Schaumberger M, Priglinger SG, Mueller AJ, Gass
CA, Anselm Kampik A. Retina 2004; 24: 582-590 IF: 3,478 87. Transglutaminase as a Modifying Enzyme of the Extracellular Matrix in PVR Mem-
branes Tissue. Priglinger SG, May CA, Neubauer AS, Alge CS, Schonfeld CL, Kampik A,
Welge-Lussen U. Invest Ophthalmol Vis Sci. 2003 Jan;44(1):355-64. IF: 3,582 88. Optical coherence tomography for the detection of laser in situ keratomileusis in do-
nor corneas. Priglinger SG, Neubauer AS, May CA, Alge CS, Wolf AH, Mueller A, Ludwig
K, Kampik A, Welge-Luessen U. Cornea. 2003 Jan;22(1):46-50. IF: 1,853 89. Alkylphosphocholines inhibit proliferation of human retinal pigment epithelial cells.
Eibl KH, Banas B, Schoenfeld CL, May CA, Neubauer AS, Priglinger S, Kampik A, Welge- Lussen U. Invest Ophthalmol Vis Sci. 2003 Aug;44(8):3556-61. IF: 3,582 90. Comparative proteome analysis of native differentiated and cultured dedifferentiated
human RPE cells. Alge CS, Suppmann S, Priglinger SG, Neubauer AS, May CA, Hauck S,
Welge-Lussen U, Ueffing M, Kampik A. Invest Ophthalmol Vis Sci. 2003 Aug;44(8):3629- 91. Tele-screening for diabetic retinopathy with the retinal thickness analyzer. Neubauer
AS, Welge-Lussen UC, Thiel MJ, Alge C, Priglinger SG, Hirneiss C, Ulbig MW, Kampik A. Diabetes Care. 2003 Oct;26(10):2890-7.IF: 7,851 92. Vitreoretinal morphology of plasmin-treated human eyes. Gandorfer A, Priglinger S,
Schebitz K, Hoops J, Ulbig M, Ruckhofer J, Grabner G, Kampik A. Am J Ophthalmol. 93. Epiretinal pathology of vitreomacular traction syndrome.Gandorfer A, Rohleder M,
Kampik A. Br J Ophthalmol. 2002 Aug;86(8):902-9. 94. Sterile Structural Imaging of Donor Cornea by Optical Coherence Tomography.
Neubauer AS, Priglinger SG, Thiel MJ, May CA, Welge-Lüßen UC. Cornea. 2002 95. Consenting to cornea donation: influencing factors. Krieglstein TR, Welge-Lussen UC,
Priglinger S, Kampik A, Priemer F, Neubauer AS. Graefes Arch Clin Exp Ophthalmol. 2002 96. Retinal Pigment Epithelium Is Protected Against Apoptosis by alphaB-Crystallin.
Alge CS, Priglinger SG, Neubauer AS, Kampik A, Zillig M, Bloemendal H, Welge-Lussen U. Invest Ophthalmol Vis Sci. 2002 Nov;43(11):3575-82. IF: 3,582 97. PUVA downregulates whn expression in primary mouse keratinocytes. Alge C, Baxter
RM, Doyle ME, Moor AC, Brissette JL, Ortel B. J Photochem Photobiol B. 2001 Nov 98. Hornhautspende: Einflussfaktoren der Einwilligung. Krieglstein TR, Neubauer AS,
Welge-Lüßen U, Priglinger S, Kampik A, Priemer F. Ophthalmologe 2001 Jun;98(6):545-9. 99. Elektronische oder papiergebundene Patientenakte -ein Kosten-Nutzenvergleich.
Neubauer AS, Priglinger S, Ehrt O. Ophthalmologe 2001 Nov;98(11): 1083-1088. IF: 1,133 Comparison of foveal thickness measured with the retinal thickness analyzer
and optical coherence tomography. Neubauer AS, Priglinger S, Ullrich S, Bechmann M,
Thiel MJ, Ulbig MW, Kampik A. Retina. 2001;21(6): 596-601. IF: 3,478 Detection of the WT1 transcript by RT-PCR in complete remission has no
prognostic relevance in de novo acute myeloid leukemia. Gaiger A, Schmid D, Heinze
G, Linnerth B, Greinix H, Kalhs P, Tisljar K, Priglinger S, Laczika K, Mitterbauer M, Novak M, Mitterbauer G, Mannhalter C, Haas OA, Lechner K, Jager U. Leukemia. 1998; 12:1886-


Microsoft word - colds (upper respiratory infection) handout (1360_0).doc

Over-The-Counter (OTC) Medications for the Relief of Upper Respiratory Infections Available at Student Health Service Remember: These are not "cures" for URI’s ! Take only the manufacturer's recommended dose - read the label!! The basic medications include analgesics, antihistamines, decongestants, expectorants, cough suppressants, & throat sprays or lozenges. Generic products

Microsoft word - livazo master consolidated smpc 18 nov 2011.doc

Pitavastatin 1mg, 2mg & 4mg film-coated tablets Master Consolidated SmPC SUMMARY OF PRODUCT CHARACTERISTICS NAME OF THE MEDICINAL PRODUCT 1mg: Livazo 1mg film-coated tablets. 2mg: Livazo 2mg film-coated tablets. 4mg: Livazo 4mg film-coated tablets. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1mg: Each film-coated tablet contains pitavastatin calcium equivalent to

Copyright © 2010-2014 Pdf Physician Treatment